Themison
Themison is building an AI-powered platform designed to be the operational brain for clinical trial sites, aiming to reduce complexity and improve efficiency. The platform connects teams, coordinates execution, and brings clarity to trial workflows without replacing existing systems. It focuses on streamlining communication, clarifying protocols, and turning data into actionable insights to help clinical trial sites manage their operations more effectively. The company emphasizes co-building its product with site staff, ensuring it addresses the real-world frustrations and needs of professionals in clinical research. Themison is designed to facilitate faster execution, reduce administrative work and errors, provide shared visibility across trials, and enable seamless collaboration. They are currently piloting with trial sites in Europe and inviting applications for early access.
Themison
Themison is building an AI-powered platform designed to be the operational brain for clinical trial sites, aiming to reduce complexity and improve efficiency. The platform connects teams, coordinates execution, and brings clarity to trial workflows without replacing existing systems. It focuses on streamlining communication, clarifying protocols, and turning data into actionable insights to help clinical trial sites manage their operations more effectively. The company emphasizes co-building its product with site staff, ensuring it addresses the real-world frustrations and needs of professionals in clinical research. Themison is designed to facilitate faster execution, reduce administrative work and errors, provide shared visibility across trials, and enable seamless collaboration. They are currently piloting with trial sites in Europe and inviting applications for early access.
TL;DR
What they do: AI-powered SaaS platform to coordinate and streamline operations at clinical trial sites
Stage: Private / Pre-Seed (founded 2023), running private beta/pilots in Europe
HQ: Copenhagen, Denmark
Team size: Approximately 1–10 employees
Early investor: Antler
Company Overview
Problem Domain
Clinical trial site operations and coordination
Founded
2023
Industry
Healthtech / SaaS
Funding Track Record
170000.00
Early funding reported in mid/late 2023; public profiles list Antler as investor and a seed/pre‑seed ticket (approx. €150k reported by some sources).
Investor Signal
“Antler-backed (early investor)”